BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 10791201)

  • 1. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
    Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
    J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
    Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
    Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
    Bock E; Becker W; Scheele J; Wolf F
    Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
    Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
    Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
    Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
    Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
    Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
    Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
    Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
    Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG
    J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunodetection of occult carcinoembryonic antigen-producing cancer.
    Haseman MK; Brown DW; Keeling CA; Reed NL
    J Nucl Med; 1992 Oct; 33(10):1750-6. PubMed ID: 1403140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26.
    Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G
    Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pilot study with the monoclonal antibody IOR-C5 as a potential agent of radioimmunoscintigraphy in colorectal cancer].
    Oliva JP; Pimentel G; Borrón M; Peralta R; Ortiz R; Oliver B; Díaz N; Sánchez I; Vázquez AM; Baum RP
    Rev Esp Med Nucl; 2001 Jun; 20(4):282-8. PubMed ID: 11940415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?
    Fuster D; Maurel J; Muxí A; Setoain X; Ayuso C; Martín F; Ortega ML; Fuertes S; Pons F
    Q J Nucl Med; 2003 Jun; 47(2):109-15. PubMed ID: 12865871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
    Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
    Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management.
    Sirisriro R; Podoloff DA; Patt YZ; Curley SA; Kasi LP; Bhadkamkar VA; Kim EE; Murray JL; Smith R; Haynie TP
    Nucl Med Commun; 1996 Jul; 17(7):568-76. PubMed ID: 8843115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
    Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
    Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of immunoscintigraphy in the detection of recurrent colorectal cancer.
    Baulieu F; Bourlier P; Scotto B; Mor C; Eder V; Picon L; De Calan L; Dorval E; Pottier JM; Baulieu JL
    Nucl Med Commun; 2001 Dec; 22(12):1295-304. PubMed ID: 11711899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
    Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
    J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.